Literature DB >> 4937902

Renal transplantation in patients with Australia antigenemia.

W Reed, Z J Lucas, R Kempson, R Cohn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4937902

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  7 in total

1.  Clinical manifestations of infections with herpesviruses after kidney transplantation: a prospective study of various syndromes.

Authors:  S Naraqi; O Jonasson; G G Jackson; H M Yamashiroya
Journal:  Ann Surg       Date:  1978-08       Impact factor: 12.969

2.  Virus infections after transplantation in man. Brief review.

Authors:  M Ho
Journal:  Arch Virol       Date:  1977       Impact factor: 2.574

3.  HBs antigenemia in renal allograft recipients.

Authors:  R N Fine; M H Malekzadeh; A J Pennisi; C H Uittenbogaart; R B Ettenger; B H Landing; H T Wright
Journal:  Ann Surg       Date:  1977-04       Impact factor: 12.969

4.  Forty-day fever. An epidemic of cytomegalovirus disease in a renal transplant population.

Authors:  A S Coulson; Z J Lucas; M Condy; R Cohn
Journal:  West J Med       Date:  1974-01

5.  Immunosuppression, liver injury, and hepatitis in renal, hepatic, and cardiac homograft recipients: with particular reference to the Australia antigen.

Authors:  M Torisu; T Yokoyama; H Amemiya; P F Kohler; G Schroter; G Martineau; I Penn; W Palmer; C G Halgrimson; C W Putnam; T E Starzl
Journal:  Ann Surg       Date:  1971-10       Impact factor: 12.969

6.  Hepatitis with Australia antigenemia following renal transplantation.

Authors:  A Aronoff; M H Gault; S N Huang; S Lal; K T Wu; M D Moinuddin; L Spence; L D MacLean
Journal:  Can Med Assoc J       Date:  1973-01-06       Impact factor: 8.262

7.  Cytomegalovirus: Clinical virological correlations in renal transplant recipients.

Authors:  R L Simmons; C Lopez; H Balfour; J Kalis; L C Rattazzi; J S Najarian
Journal:  Ann Surg       Date:  1974-10       Impact factor: 12.969
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.